SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001657312-20-000014
Filing Date
2020-02-04
Accepted
2020-02-04 12:53:08
Documents
6
Period of Report
2020-02-04

Document Format Files

Seq Description Document Type Size
1 6-K mgtchange6kcover20200204.htm 6-K 26991
2 EXHIBIT 1 veronapharmamanagementch.htm EX-1 15398
3 veronapharmamanagementch001.jpg GRAPHIC 275026
4 veronapharmamanagementch002.jpg GRAPHIC 257456
5 veronapharmamanagementch003.jpg GRAPHIC 292844
6 veronapharmamanagementch004.jpg GRAPHIC 99077
  Complete submission text file 0001657312-20-000014.txt   1317016
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38067 | Film No.: 20572375
SIC: 2834 Pharmaceutical Preparations